These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 18423197)

  • 1. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
    Hanna J; Markoulaki S; Schorderet P; Carey BW; Beard C; Wernig M; Creyghton MP; Steine EJ; Cassady JP; Foreman R; Lengner CJ; Dausman JA; Jaenisch R
    Cell; 2008 Apr; 133(2):250-64. PubMed ID: 18423197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
    Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
    PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of pancreatic beta cells into induced pluripotent stem cells.
    Stadtfeld M; Brennand K; Hochedlinger K
    Curr Biol; 2008 Jun; 18(12):890-4. PubMed ID: 18501604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempting to Convert Primed Porcine Embryonic Stem Cells into a Naive State Through the Overexpression of Reprogramming Factors.
    Park TY; Choi KH; Lee DK; Oh JN; Kim SH; Lee CK
    Cell Reprogram; 2018 Oct; 20(5):289-300. PubMed ID: 30277824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb.
    Feng B; Jiang J; Kraus P; Ng JH; Heng JC; Chan YS; Yaw LP; Zhang W; Loh YH; Han J; Vega VB; Cacheux-Rataboul V; Lim B; Lufkin T; Ng HH
    Nat Cell Biol; 2009 Feb; 11(2):197-203. PubMed ID: 19136965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the murine reprogramming factors in the induction of pluripotency.
    Sridharan R; Tchieu J; Mason MJ; Yachechko R; Kuoy E; Horvath S; Zhou Q; Plath K
    Cell; 2009 Jan; 136(2):364-77. PubMed ID: 19167336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the reprogramming potential of B cells and comprehending its clinical and therapeutic perspective.
    Rani R; Nayak M; Nayak B
    Transpl Immunol; 2023 Jun; 78():101804. PubMed ID: 36921730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4-induced pluripotency in adult neural stem cells.
    Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
    Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
    Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
    Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
    Brambrink T; Foreman R; Welstead GG; Lengner CJ; Wernig M; Suh H; Jaenisch R
    Cell Stem Cell; 2008 Feb; 2(2):151-9. PubMed ID: 18371436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.
    Hanna JH; Saha K; Jaenisch R
    Cell; 2010 Nov; 143(4):508-25. PubMed ID: 21074044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts.
    Tsubooka N; Ichisaka T; Okita K; Takahashi K; Nakagawa M; Yamanaka S
    Genes Cells; 2009 Jun; 14(6):683-94. PubMed ID: 19476507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency.
    Son MY; Choi H; Han YM; Cho YS
    Stem Cells; 2013 Nov; 31(11):2374-87. PubMed ID: 23939908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activation of the reprogramming transcription factors.
    Guo J; Li ZC; Feng YH
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.